Monday, March 31, 2025
spot_img

Abacus Global Management Reports Fourth Quarter and Full Year 2024 Results

– Delivered Record Full Year Revenue and Growth While Executing on Strategic Acquisitions and Initiatives –

– Fourth Quarter 2024 Total Revenue Grows 40% Year-over-Year to $33.2 Million –

– Full-Year Policy Originations Grow 63% to 1,034 –

Initiating Full Year 2025 Outlook for Adjusted Net Income Between $70 and $78 Million –

ORLANDO, Fla., March 27, 2025 (GLOBE NEWSWIRE) — Abacus Global Management (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today reported results for the fourth quarter ended December 31, 2024.

“We concluded 2024 with another solid quarter of profitable growth and significant milestones, capping off a record year for Abacus. In addition to our strong financial results, we undertook meaningful strategic initiatives that have significantly expanded our business. Over the past 12 months, we strengthened our executive team through key hires, successfully raised substantial equity capital to fuel our growth initiatives, secured significant debt financing to optimize our capital structure, completed two strategic acquisitions that expanded our capabilities and market reach, and dramatically grew both the scope and scale of our operations across multiple business lines and geographies.”

“Subsequent to year-end, in early March, we successfully rebranded to Abacus Global Management, which better reflects our evolution and global market presence. As we look ahead, we’re off to a strong start in 2025 – expecting to once again grow our adjusted net income for the full year by over 50%. We remain very excited about our vast market opportunity and are well positioned to capitalize on our momentum to drive long-term growth and create shareholder value.”

Fourth Quarter 2024 Highlights

  • Total revenue for the fourth quarter of 2024 grew 40% to $33.2 million, compared to $23.6 million in the prior-year period. The increase was primarily driven by higher active management revenue, increased capital deployed and more policies sold directly to third parties.
  • Origination capital deployment for the fourth quarter of 2024 increased 41% to $96.6 million, compared to $68.3 million in the prior-year period; number of policy originations for the fourth quarter of 2024 was 214.
  • GAAP net loss attributable to shareholders for the fourth quarter of 2024 was $18.3 million, compared to net loss of $6.2 million in the prior-year period, primarily driven by an $18.6 million increase in non-cash expenses related to employee stock compensation, as well as non-recurring acquisition-related costs and higher interest expense.
  • Adjusted net income (a non-GAAP financial measure) for the fourth quarter of 2024 more than doubled to $13.4 million, compared to $5.9 million in the prior-year period.
  • Adjusted EBITDA (a non-GAAP financial measure) for the fourth quarter of 2024 grew 51% to $16.6 million, compared to $11.1 million in the prior-year period. Adjusted EBITDA margin (a non-GAAP financial measure) for the fourth quarter of 2024 was 50.0%, compared to 46.7% in the prior-year period.
  • Annualized return on invested capital (ROIC) (a non-GAAP financial measure) for the fourth quarter of 2024 was 11%.
  • Annualized Return on equity (ROE) (a non-GAAP financial measure) for the fourth quarter of 2024 was 13%.

Full Year 2024 Results

  • Full year 2024 total revenues grew 69% to $111.9 million, compared to $66.4 million in the prior year, primarily driven by higher active management revenue, increased capital deployed and more policies sold directly to third parties.
  • Originations capital deployment for the full year 2024 was $327.8 million, an increase of 50% from the prior year; number of policy originations grew 63% to 1,034, compared to 633 in the prior year.
  • GAAP net loss attributable to shareholders for the full year 2024 was $24.0 million, compared to net GAAP income of $9.5 million in the prior year.
  • Adjusted net income (a non-GAAP financial measure) for the full year 2024 increased 58% to $46.5 million, compared to $29.4 million in the prior year, primarily due to increases in non-cash stock-based compensation and related tax effect, acquisition-related costs, and acquired intangible asset amortizations.
  • Adjusted EBITDA for the full year 2024 grew 57% to $61.6 million, compared to $39.3 million in the prior year. Adjusted EBITDA margin (a non-GAAP measure) for the full year 2024 was 55.0%, compared to 59.2% in the prior year.
  • Return on invested capital (ROIC) (a non-GAAP measure defined below) for the full year 2024 was 15%.
  • Return on equity (ROE) (a non-GAAP measure defined below) for the full year 2024 was 17%.

Liquidity and Capital

As of December 31, 2024, the Company had cash and cash equivalents of $128.8 million, balance sheet policy assets of $371.4 million and outstanding long-term debt of $342.4 million.

2025 Outlook

The company is initiating its full year 2025 outlook for Adjusted net income to be between $70 million and $78 million. The range implies growth of between 51% to 68% compared to full year 2024 Adjusted net income of $46.5 million.

The Company is unable to provide a comparable outlook for, or a reconciliation to net income because it cannot provide a meaningful or accurate calculation or estimation of certain reconciling items without unreasonable effort. Its inability to do so is due to the inherent difficulty in forecasting the timing of items that have not yet occurred and quantifying certain amounts that are necessary for such reconciliation, including variations in effective tax rate, expenses to be incurred for acquisition activities, and other one-time or exceptional items.

For a definition of Adjusted net income, see “Non-GAAP Financial Information” below.

Webcast and Conference Call

A webcast and conference call to discuss the Company’s results will be held today beginning at 5:00 p.m. (Eastern Time). A live webcast of the conference call will be available on Abacus’ investor relations website at ir.abacusgm.com. The dial-in number for the conference call is (877) 407-9716 (toll-free) or (201) 493-6779 (international). Please dial the number 10 minutes prior to the scheduled start time.

A webcast replay of the call will be available at ir.abacusgm.com for one year following the call.

Non-GAAP Financial Information

Adjusted Net Income, a non-GAAP financial measure, is defined as net income (loss) attributable to Abacus adjusted for non-controlling interest income, amortization, change in fair value of warrants and non-cash stock-based compensation and the related tax effect of those adjustments. Management believes that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance. A reconciliation of Adjusted Net Income to Net income attributable to Abacus, the most directly comparable GAAP measure, appears below.

Adjusted EBITDA, a non-GAAP financial measure, is defined as net income (loss) attributable to Abacus adjusted for depreciation expense, amortization, interest expense, income tax and other non-cash and certain non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results that do not directly relate to business performance within Abacus’ control. A reconciliation of Adjusted EBITDA to Net income attributable to Abacus Global Management, the most directly comparable GAAP measure, appears below.

Adjusted EBITDA margin, a non-GAAP financial measure, is defined as Adjusted EBITDA divided by Total revenues. A reconciliation of Adjusted EBITDA margin to Net income margin, the most directly comparable GAAP measure, appears below.

Annualized return on invested capital (ROIC), a non-GAAP financial measure, is defined as Adjusted net income for the quarter divided by the result of Total Assets less Intangible assets, net, Goodwill and Current Liabilities multiplied by four. ROIC is not a measure of financial performance under GAAP. We believe ROIC should be considered in addition to, not as a substitute for, operating income or loss, net income or loss, cash flows provided by or used in operating, investing and financing activities or other income statement or cash flow statement line items reported in accordance with GAAP.

Annualized return on equity (ROE), a non-GAAP financial measure, is defined as Adjusted net income divided by total shareholder equity multiplied by four. ROE is not a measure of financial performance under GAAP. We believe ROE should be considered in addition to, not as a substitute for, operating income or loss, net income or loss, cash flows provided by or used in operating, investing and financing activities or other income statement or cash flow statement line items reported in accordance with GAAP. The below table presents our calculation of ROE.

Forward-Looking Statements

All statements in this press release (and oral statements made regarding the subjects of this press release) other than historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors that could cause actual results to differ materially from such statements, many of which are outside the control of Abacus. Forward-looking information includes but is not limited to statements regarding: Abacus’s financial and operational outlook; Abacus’s operational and financial strategies, including planned growth initiatives and the benefits thereof, Abacus’s ability to successfully effect those strategies, and the expected results therefrom. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” “prospects,” “will,” “would,” “will continue,” “will likely result,” and similar expressions (including the negative versions of such words or expressions).

While Abacus believes that the assumptions concerning future events are reasonable, it cautions that there are inherent difficulties in predicting certain important factors that could impact the future performance or results of its business. The factors that could cause results to differ materially from those indicated by such forward-looking statements include, but are not limited to: the fact that Abacus’s loss reserves are bases on estimates and may be inadequate to cover its actual losses; the failure to properly price Abacus’s insurance policies; the geographic concentration of Abacus’s business; the cyclical nature of Abacus’s industry; the impact of regulation on Abacus’s business; the effects of competition on Abacus’s business; the failure of Abacus’s relationships with independent agencies; the failure to meet Abacus’s investment objectives; the inability to raise capital on favorable terms or at all; the effects of acts of terrorism; and the effectiveness of Abacus’s control environment, including the identification of control deficiencies.

These forward-looking statements are also affected by the risk factors, forward-looking statements and challenges and uncertainties set forth in documents filed by Abacus with the U.S. Securities and Exchange Commission from time to time, including the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and subsequent periodic reports. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Abacus cautions you not to place undue reliance on the forward-looking statements contained in this press release. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Abacus assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Abacus does not give any assurance that it will achieve its expectations.

About Abacus Global Management

Abacus Global Management (NASDAQ: ABL) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.

Contacts :

Investor Relations

Robert F. Phillips – SVP Investor Relations and Corporate Affairs
[email protected]
(321) 290-1198

David Jackson – IR/Capital Markets Associate
[email protected]
(321) 299-0716

Abacus Global Management Public Relations
[email protected]

 
ABACUS GLOBAL MANAGEMENT, INC. CONSOLIDATED BALANCE SHEET
     
  December 31, December 31,
    2024     2023  
ASSETS    
CURRENT ASSETS:    
Cash and cash equivalents $ 131,944,282   $ 25,588,668  
Equity securities, at fair value       2,252,891  
Accounts receivable   15,785,531     2,149,111  
Accounts receivable, related party   7,113,369     79,509  
Due from affiliates   1,527,062     1,007,528  
Other receivables        
Income taxes receivable   2,099,673      
Prepaid expenses and other current assets   1,094,729     699,127  
Total current assets   159,564,646     31,776,834  
     
Property and equipment, net   1,025,066     400,720  
Intangible assets, net   79,786,793     29,623,130  
Goodwill   238,296,200     140,287,000  
Operating right-of-use assets   4,722,573     1,893,659  
Life settlement policies, at cost   1,083,977     1,697,178  
Life settlement policies, at fair value   370,398,447     122,296,559  
Noncurrent management and performance fee receivable, related party   13,379,301      
Available-for-sale securities, at fair value   2,205,904     1,105,935  
Other investments, at cost   1,850,000     1,650,000  
Other assets   1,851,845     998,945  
Equity securities, at fair value       96,107  
TOTAL ASSETS $ 874,164,752   $ 331,826,067  
     
LIABILITIES AND STOCKHOLDERS’ EQUITY    
CURRENT LIABILITIES:    
Current portion of long-term debt, at fair value $ 37,430,336   $ 13,029,632  
Current portion of long-term debt   1,000,000      
Accrued expenses   6,139,472     4,354,225  
Operating lease liabilities   515,597     118,058  
Due to affiliates       5,236  
Due to former members       1,159,712  
Contract liabilities, deposits on pending settlements   2,473,543     507,000  
Accrued transaction costs   483,206      
Other current liabilities   14,423,925     3,400,734  
Income taxes payable       751,734  
Total current liabilities   62,466,079     23,326,331  
     
Long-term debt, net   224,742,029     33,818,090  
Long-term debt, at fair value, net   105,120,100     55,318,923  
Long-term debt, related party   12,525,635     37,653,869  
Noncurrent retrocession fee payables   5,312,214      
Operating lease liabilities   4,580,158     1,796,727  
Deferred tax liability   26,778,865     9,199,091  
Warrant liability   9,345,000     6,642,960  
TOTAL LIABILITIES   450,870,080     167,755,991  
     
COMMITMENTS AND CONTINGENCIES    
Preferred stock, $0.0001 par value; 1,000,000 authorized shares authorized; none issued or outstanding        
Class A common stock, $0.0001 par value; 200,000,000 authorized shares; 96,731,194 and 63,388,823 shares issued at December 31, 2024 and 2023, respectively   10,133     6,339  
Treasury stock – at cost; 1,048,226 and 146,650 shares repurchased at December 31, 2024 and 2023, respectively   (12,025,137 )   (1,283,062 )
Additional paid-in capital   494,064,113     199,826,278  
Accumulated deficit   (57,896,606 )   (34,726,135 )
Accumulated other comprehensive income       108,373  
Non-controlling interest   (857,831 )   138,283  
Total stockholders’ equity   423,294,672     164,070,076  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 874,164,752   $ 331,826,067  
     

ABACUS GLOBAL MANAGEMENT, INC. CONSOLIDATED STATEMENT OF OPERATIONS
           
  Three Months Ended December 31,   Years Ended December 31,
    2024     2023       2024     2023  
REVENUES:          
Active management $ 29,041,030   $ 21,274,316     $ 102,819,361   $ 61,195,377  
Origination fees   1,062,910     2,233,683       5,457,147     4,203,900  
Asset management fees   2,841,481           2,841,481      
Portfolio servicing fees   232,960     187,548       772,169     1,002,174  
Technology services   33,628           33,628      
Total revenues   33,212,009     23,695,547       111,923,786     66,401,451  
COST OF REVENUES (excluding depreciation and amortization stated below):        
Cost of revenue (including stock-based compensation)   3,719,321     1,570,994       11,371,733     6,390,921  
Related party cost of revenue       91,476           99,456  
Cost of revenue (including stock-based compensation)   3,719,321     1,662,470       11,371,733     6,490,377  
Gross Profit   29,492,688     22,033,077       100,552,053     59,911,074  
OPERATING EXPENSES:          
Sales and marketing   2,411,442     1,788,748       9,063,384     4,905,747  
General and administrative (including stock-based compensation)   40,338,172     15,369,189       81,734,518     26,482,571  
Loss on change in fair value of debt   799,024     2,046,193       4,835,351     2,356,058  
Unrealized loss (gain) on investments   1,458,173     (877,754 )     238,012     (1,369,112 )
Realized gain on investments   (1,484,322 )         (2,341,066 )    
Depreciation and amortization expense   2,732,373     1,712,934       7,910,158     3,409,928  
Total operating expenses   46,254,862     20,039,310       101,440,357     35,785,192  
Operating (loss) income   (16,762,174 )   1,993,767       (888,304 )   24,125,882  
OTHER INCOME (EXPENSE):          
Loss on change in fair value of warrant liability   5,785,000     (3,260,960 )     (2,702,040 )   (4,204,360 )
Interest (expense)   (5,861,740 )   (6,246,126 )     (18,279,686 )   (9,866,821 )
Interest income   727,863     523,481       2,398,691     594,764  
Other income (expense)   (94,570 )   (144,879 )     38,040     (146,443 )
Total other income (expense)   556,553     (9,128,484 )     (18,544,995 )   (13,622,860 )
Net (loss) income before provision for income taxes   (16,205,621 )   (7,134,717 )     (19,433,299 )   10,503,022  
Income tax expense   2,803,883     (769,885 )     5,484,738     1,468,535  
NET (LOSS) INCOME   (19,009,504 )   (6,364,832 )     (24,918,037 )   9,034,487  
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST   (752,271 )   (142,447 )     (956,987 )   (482,139 )
NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (18,257,233 ) $ (6,222,385 )   $ (23,961,050 ) $ 9,516,626  
           
(LOSS) EARNINGS PER SHARE:          
(Loss) earnings per share—basic $ (0.22 ) $ (0.10 )   $ (0.34 ) $ 0.17  
(Loss) earnings per share—diluted $ (0.22 ) $ (0.10 )   $ (0.34 ) $ 0.16  
           
Weighted-average stock outstanding—basic [1]   81,784,013     63,352,743       70,761,830     56,951,414  
Weighted-average stock outstanding—diluted [1]   81,784,013     64,169,227       70,761,830     57,767,898  
           
[1] The 2023 number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the Business Combination.
           

ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED NET INCOME AND ADJUSTED EPS
           
    Full Year Full Year For the three months ended
      2024     2023   12/31/2024 12/31/2023
Adjusted Net Income and Adjusted EPS          
Net income attributable to Abacus Life, Inc.   $ (23,961,050 ) $ 9,516,626   $ (18,257,233 ) $ (6,222,383 )
Net income attributable to non-controlling interests     (956,987 )   (482,139 )   (752,271 )   (142,447 )
Depreciation and Amortization expense     7,748,269     3,364,167     2,676,144     1,682,084  
Stock compensation expense     43,435,215     10,768,024     24,760,007     6,184,392  
Business Acquisition Accounting expenses     8,403,065         5,129,947      
Change in fair value of warrant liability     2,702,040     4,204,360     (5,785,000 )   3,260,960  
Tax impact of executive RSUs     9,151,161     2,069,993     5,632,379     1,161,722  
Adjusted Net Income   $ 46,521,713   $ 29,441,031   $ 13,403,973   $ 5,924,328  
           
Weighted-average shares of Class A common stock outstanding     70,761,830     56,951,414     81,784,013     64,169,227  
Adjusted EPS   $ 0.66   $ 0.52   $ 0.16   $ 0.09  
           
           
ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED EBITDA
           
    Full Year Full Year For the three months ended
Adjusted EBITDA     2024     2023   12/31/2024 12/31/2023
Net income   $ (24,918,037 ) $ 9,034,487   $ (19,009,504 ) $ (6,364,830 )
Depreciation and Amortization     7,910,159     3,409,928     2,732,374     1,712,934  
Interest expense     18,279,686     9,866,821     5,861,740     6,246,126  
Interest income     (2,398,691 )   (594,764 )   (727,863 )   (523,481 )
Income Tax     5,484,738     1,468,535     2,803,883     (769,884 )
Stock compensation     43,435,215     10,768,024     24,760,007     6,184,392  
Other (Income) / Expenses     (38,040 )   146,443     94,570     144,878  
Change in fair value of warrant liability     2,702,040     4,204,360     (5,785,000 )   3,260,960  
Business Acquisition expenses     8,403,065         5,129,947      
Change in fair value of debt     4,835,351     2,356,058     799,024     2,046,193  
Realized and Unrealized loss / (gain) on investments     (2,103,054 )   (1,369,112 )   (26,149 )   (877,756 )
Adjusted EBITDA   $ 61,592,432   $ 39,290,780   $ 16,633,029   $ 11,059,532  
           
Revenue   $ 111,923,786   $ 66,401,451   $ 33,212,009   $ 23,695,547  
           
Adjusted EBITDA Margin     55 %   59 %   50 %   47 %
Net (Loss) Income Margin     -22 %   14 %   -57 %   -27 %
           

ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED RETURN ON INVESTED CAPITAL (ROIC)  
               
    For the 3 mo period
ended
YTD   For the 3 mo period
ended
YTD  
    9/30/2024 9/30/2024   12/31/2024 12/31/2024  
Total Assets   $ 477,309,168   $ 477,309,168     $ 874,164,752   $ 553,012,056   (1)
Less:              
Intangible assets, net     (24,653,141 )   (24,653,141 )     (79,786,793 )   (39,710,021 ) (1)
Goodwill     (139,930,190 )   (139,930,190 )     (238,296,200 )   (164,610,895 ) (1)
Total current liabilities     (23,862,348 )   (23,862,348 )     (62,466,079 )   (41,386,709 ) (1)
Total Invested Capital   $ 288,863,489   $ 288,863,489     $ 493,615,680   $ 307,304,431    
               
Adjusted Net Income   $ 14,879,252   $ 33,322,456     $ 13,403,973   $ 46,521,713    
Adjusted Annualized ROIC     21 %   15 %     11 %   15 %  
               
Note:              
(1) Weighted Average for the full year.              
               
               
ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED RETURN ON EQUITY (ROE)  
               
    For the 3 mo period
ended
YTD   For the 3 mo period
ended
YTD  
    9/30/2024 9/30/2024   12/31/2024 12/31/2024  
Total stockholders’ equity   $ 257,939,628   $ 257,939,628     $ 423,294,672   $ 275,856,140   (1)
               
Adjusted Net Income   $ 14,879,252   $ 33,322,456     $ 13,403,973   $ 46,521,713    
Adjusted Annualized ROE     23 %   17 %     13 %   17 %  
               
Note:              
(1) Weighted Average for the full year            

Powered by SlickText.com

Hot this week

First Three Children to Commence Treatment With Ryoncil®

United States Centers for Medicare and Medicaid Services (CMS)...

FirstFarms A/S: Confirmed case of Foot and Mouth Disease on farm in Slovakia

The Slovak authorities have confirmed an outbreak of Foot...

Mandatory Notification of Trade

Please refer to the attached forms of notification of...

Possible symptoms of Foot and Mouth Disease in one animal in FirstFarms’ herd in Slovakia

On 30 March 2025, FirstFarms has seen possible symptoms...

Topics

First Three Children to Commence Treatment With Ryoncil®

United States Centers for Medicare and Medicaid Services (CMS)...

FirstFarms A/S: Confirmed case of Foot and Mouth Disease on farm in Slovakia

The Slovak authorities have confirmed an outbreak of Foot...

Mandatory Notification of Trade

Please refer to the attached forms of notification of...

EHang’s EH216-S eVTOL Operators Obtain Air Operator Certificates

GUANGZHOU, China, March 30, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img